The latest in policy & regulation: 4 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: Brainomix Says Biomarker Qualification Is Next Step For Its FDA-Cleared Lung AI Software.
Abbott, Dexcom grapple with diabetes coverage ahead of planned Medicare expansion
Abbott said it is facing pricing pressure and slower growth ahead of a planned coverage expansion for people with Type 2 diabetes. Competitor Dexcom, however, did not experience the same slowdown.
Follow the full firehose on the HTC Wire, refreshed automatically every day.
Reach the people behind these stories. HealthTech Cube demand gen programs deliver qualified healthcare technology leads from $49.50 per lead - see packages or download the 2026 media kit.